We are live on ! Find out more
WA

Wasatch Advisors Portfolio holdings

AUM $15.3B
1-Year Est. Return 25.06%
This Fund
S&P 500
This Quarter Est. Return
+8.33%
1 Year Est. Return
+25.06%
3 Year Est. Return
+87.66%
5 Year Est. Return
+80.4%
10 Year Est. Return
+874.7%
AUM
$16.5B
AUM Growth
+$455M
Cap. Flow
-$513M
Cap. Flow %
-3.11%
Top 10 Hldgs %
23.61%
Holding
273
New
16
Increased
90
Reduced
147
Closed
16

Top Buys

Rank Stock Value
1
GLOB icon
Globant
GLOB
+$75.4M
2
SILK
Silk Road Medical, Inc. Common Stock
SILK
+$73.1M
3
CERT icon
Certara
CERT
+$56.7M
4
FOUR icon
Shift4
FOUR
+$40.8M
5
FOXF icon
Fox Factory Holding Corp
FOXF
+$39.1M

Top Sells

Rank Stock Value
1
ABCM
Abcam PLC
ABCM
+$110M
2
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$62M
3
MEDP icon
Medpace
MEDP
+$60.2M
4
ENSG icon
The Ensign Group
ENSG
+$53M
5
VVV icon
Valvoline
VVV
+$52.2M

Sector Composition

Rank Sector Weight
1 Technology 26.67%
2 Healthcare 18.3%
3 Consumer Discretionary 16.93%
4 Industrials 14.53%
5 Financials 12.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ATRC icon
101
AtriCure
ATRC
$2.08B
$30M 0.18%
608,132
+196
+0% +$9.03K
POWI icon
102
Power Integrations
POWI
$3.15B
$30M 0.18%
316,478
+11,743
+4% +$980K
CAE icon
103
CAE Inc. Common Shares
CAE
$8.43B
$29.9M 0.18%
1,335,853
-174,808
-12% -$3.87M
ICFI icon
104
ICF International
ICFI
$1.5B
$29.8M 0.18%
239,623
-21,822
-8% -$2.52M
RYZ
105
Ryerson Holding Corp
RYZ
$1.48B
$28.8M 0.17%
663,097
-127,760
-16% -$4.74M
VKTX icon
106
Viking Therapeutics
VKTX
$3.86B
$27.7M 0.17%
1,709,475
+4,031
+0.2% +$84.5K
KYMR icon
107
Kymera Therapeutics
KYMR
$8.66B
$27.6M 0.17%
1,199,350
+161,936
+16% +$4.64M
FBK icon
108
FB Financial Corp
FBK
$2.98B
$27.4M 0.17%
975,754
-101,575
-9% -$2.89M
ADUS icon
109
Addus HomeCare
ADUS
$2.22B
$27.3M 0.17%
294,813
+39,419
+15% +$3.76M
ANDE icon
110
Andersons Inc
ANDE
$2.39B
$25.6M 0.15%
+554,540
New +$23.2M
DYN icon
111
Dyne Therapeutics
DYN
$4.15B
$25.4M 0.15%
2,259,535
-667,743
-23% -$7.88M
LOVE icon
112
LoveSac
LOVE
$242M
$24.6M 0.15%
911,619
-41,699
-4% -$1.06M
DNLI icon
113
Denali Therapeutics
DNLI
$3.78B
$24.6M 0.15%
832,297
+274,130
+49% +$7.71M
CMC icon
114
Commercial Metals
CMC
$7.47B
$23.9M 0.14%
453,117
-44,081
-9% -$2.06M
SFBS
115
ServisFirst Bancshares
SFBS
$4.89B
$23.8M 0.14%
581,445
-60,243
-9% -$2.78M
WEAV icon
116
Weave Communications
WEAV
$555M
$23M 0.14%
2,067,765
-811,137
-28% -$5.42M
KLRS
117
Kalaris Therapeutics
KLRS
$80.4M
$22.6M 0.14%
288,874
+234,095
+427% +$22.3M
FNA
118
DELISTED
Paragon 28, Inc.
FNA
$22.3M 0.13%
1,254,664
-2,603
-0.2% -$46.8K
HWC icon
119
Hancock Whitney
HWC
$6.2B
$22.2M 0.13%
578,417
-46,407
-7% -$1.72M
SGMO
120
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$22.2M 0.13%
17,052,440
+3,410,023
+25% +$4.66M
GOOS
121
Canada Goose Holdings
GOOS
$901M
$22M 0.13%
1,234,419
-2,757
-0.2% -$49.6K
AIN icon
122
Albany International
AIN
$2.09B
$22M 0.13%
235,442
-25,692
-10% -$2.31M
CCS icon
123
Century Communities
CCS
$1.98B
$21.3M 0.13%
277,658
-237,704
-46% -$15.9M
VSH icon
124
Vishay Intertechnology
VSH
$4.59B
$21.1M 0.13%
717,948
-355,904
-33% -$8.7M
VSTO
125
DELISTED
Vista Outdoor Inc.
VSTO
$20.8M 0.13%
751,860
-402,197
-35% -$10.9M
3 4
5
6 7

Similar funds

UM
UniSuper Management Melbourne, Victoria, Australia $15.3B AUM 29.4% 1-Year Est. Return
RFC
Regions Financial Corp Birmingham, Alabama $15.4B AUM 21.7% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $15.1B AUM 26.53% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return
NMO
Newlands Management Operations Dallas, Texas $15.5B AUM 25.52% 1-Year Est. Return
AT
AMF Tjänstepension Stockholm, Sweden $15.1B AUM 30.1% 1-Year Est. Return

Wasatch Advisors's Q2 2023 Portfolio in Review

As of Q2 2023, Wasatch Advisors held 273 positions worth $16.5B, up 2.8% from $16.1B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Wasatch Advisors withdrew a net $513M in Q2 2023, closing 16 positions and reducing 147 holdings. Its most notable exit was Abcam PLC, an estimated $110M position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Wasatch Advisors opened a new position in Certara worth $48.9M.

  • Wasatch Advisors's largest Q2 2023 buy was Certara: 2,686,675 shares worth $48.9M.
  • Wasatch Advisors added most to Globant in Q2 2023, an estimated $75.4M increase.
  • Wasatch Advisors's biggest Q2 2023 reduction was Intra-Cellular Therapies Inc., cutting an estimated $62M.
  • Wasatch Advisors fully exited Abcam PLC in Q2 2023, selling an estimated $110M.
  • Wasatch Advisors's ten largest holdings make up 24% of its $16.5B portfolio in Q2 2023.
  • Wasatch Advisors opened 16 new positions and closed 16 in Q2 2023.
  • Wasatch Advisors's portfolio value rose 2.8% quarter-over-quarter to $16.5B.

Based on Wasatch Advisors's 13F filing for Q2 2023, filed 8 Aug 2023.